Health In Tech reaffirms FY2026 sales guidance of $45M-$50M
Health In Tech (NASDAQ: HIT) affirms its FY2026 sales outlook at $45.000M-$50.000M, unchanged from prior guidance and versus a $46.813M estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.